speb/financial-data huggingface dataset:
CURB balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 18922000.00
CURB balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 15930000.00
CURB income_statement (quarterly, 2026-03-31) — EBIT: 11525000.00
CURB income_statement (quarterly, 2026-03-31) — EBITDA: 37184000.00
CURB cash_flow (quarterly, 2026-03-31) — End Cash Position: 305778000.00
CURB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 147570000.00
CURB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 21368000.00
CURB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 0.00
CURB balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2841000.00
CURB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 9623000.00
CURB balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 140022000.00
CURB income_statement (quarterly, 2026-03-31) — Gross Profit: 42903000.00
CURB income_statement (quarterly, 2026-03-31) — Interest Expense: 7888000.00
CURB income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 7888000.00
CURB income_statement (quarterly, 2026-03-31) — Interest Income: 2908000.00
CURB income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2908000.00
CURB balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2489682000.00
CURB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -152713000.00
CURB balance_sheet (quarterly, 2026-03-31) — Investment Properties: 2115827000.00
CURB cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 172000000.00
CURB balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 0.00
CURB balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 595503000.00
CURB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 595503000.00
CURB cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 172000000.00
CURB balance_sheet (quarterly, 2026-03-31) — Minority Interest: 5088000.00
CURB income_statement (quarterly, 2026-03-31) — Minority Interests: -5000.00
CURB balance_sheet (quarterly, 2026-03-31) — Net Debt: 289725000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income: 3563000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3563000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3568000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3563000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3563000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 3568000.00
CURB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3568000.00
CURB income_statement (quarterly, 2026-03-31) — Net Interest Income: -4980000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -146209000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 172000000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 172000000.00
CURB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4980000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -4294000.00
CURB cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -6504000.00
CURB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1754157000.00
CURB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 37184000.00
CURB income_statement (quarterly, 2026-03-31) — Normalized Income: 3563000.00
CURB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 21368000.00
CURB income_statement (quarterly, 2026-03-31) — Operating Income: 7621000.00
CURB income_statement (quarterly, 2026-03-31) — Operating Revenue: 57671000.00
CURB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 105538374.00
CURB balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2841000.00
CURB income_statement (quarterly, 2026-03-31) — Other Gand A: 9623000.00
CURB income_statement (quarterly, 2026-03-31) — Other Income Expense: 996000.00
CURB balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 140022000.00
CURB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 573000.00
CURB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 11778000.00
CURB balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 67689000.00
CURB income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 996000.00
CURB balance_sheet (quarterly, 2026-03-31) — Payables: 58640000.00
CURB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 58640000.00
CURB balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CURB balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 5079000.00
CURB income_statement (quarterly, 2026-03-31) — Pretax Income: 3637000.00
CURB cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -146209000.00
CURB balance_sheet (quarterly, 2026-03-31) — Receivables: 40086000.00
CURB income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 15084000.00
CURB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 25659000.00
CURB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -60514000.00
CURB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9623000.00
CURB balance_sheet (quarterly, 2026-03-31) — Share Issued: 105538374.00
CURB income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CURB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2971000.00
CURB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1894179000.00
CURB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1754157000.00
CURB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CURB income_statement (quarterly, 2026-03-31) — Tax Provision: 69000.00
CURB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
CURB balance_sheet (quarterly, 2026-03-31) — Total Assets: 2621099000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2489682000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Debt: 595503000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1899267000.00
CURB income_statement (quarterly, 2026-03-31) — Total Expenses: 50366000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 721832000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2267627000.00
CURB balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 663192000.00
CURB income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CURB income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CURB balance_sheet (quarterly, 2026-03-31) — Working Capital: 294832000.00
CURI cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CURI balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 15430000.00
CURI income_statement (annual, 2021-12-31) — Average Dilution Earnings: -15182000.00
CURI cash_flow (annual, 2021-12-31) — Capital Expenditure: -351000.00
CURI cash_flow (annual, 2021-12-31) — Common Stock Issuance: 94101000.00
CURI balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: -222000.00
CURI balance_sheet (annual, 2021-12-31) — Goodwill: 2793000.00
CURI income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
CURI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 269000.00
CURI balance_sheet (annual, 2021-12-31) — Investmentsin Subsidiariesat Cost: 9987000.00
CURI cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 94101000.00
CURI cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CURI cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -15000000.00
CURI cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
CURI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CURI balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 1290000.00
CURI balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -222000.00
CURI balance_sheet (annual, 2021-12-31) — Other Investments: 15430000.00
CURI balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
CURI cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 55400000.00
CURI cash_flow (annual, 2021-12-31) — Purchase Of Business: -15000000.00
CURI cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CURI cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CURI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CURI income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
CURI income_statement (annual, 2022-12-31) — +Operating Expense: 78188000.00
CURI income_statement (annual, 2022-12-31) — +Total Revenue: 78043000.00
CURI balance_sheet (annual, 2022-12-31) — Accounts Payable: 6065000.00
CURI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 10899000.00
CURI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1868000.00
CURI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 358760000.00
CURI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -100000.00
CURI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 39291000.00
CURI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 39291000.00
CURI cash_flow (annual, 2022-12-31) — Amortization Of Securities: 1191000.00
CURI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 3603000.00
CURI income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
CURI income_statement (annual, 2022-12-31) — Basic Average Shares: 52787000.00
CURI income_statement (annual, 2022-12-31) — Basic EPS: -0.96
CURI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 17547000.00
CURI cash_flow (annual, 2022-12-31) — Capital Expenditure: -130000.00
CURI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4648000.00
CURI balance_sheet (annual, 2022-12-31) — Capital Stock: 5000.00
CURI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 40007000.00
CURI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 54993000.00
CURI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -218000.00
CURI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 62701000.00
CURI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -39523000.00
CURI cash_flow (annual, 2022-12-31) — Change In Account Payable: 2654000.00
CURI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -4645000.00
CURI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 3355000.00
CURI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -8250000.00
CURI cash_flow (annual, 2022-12-31) — Change In Payable: 2654000.00
CURI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1991000.00
CURI cash_flow (annual, 2022-12-31) — Change In Receivables: 11862000.00
CURI cash_flow (annual, 2022-12-31) — Change In Working Capital: 4976000.00
CURI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 11862000.00
CURI cash_flow (annual, 2022-12-31) — Changes In Cash: 22960000.00
CURI balance_sheet (annual, 2022-12-31) — Common Stock: 5000.00
CURI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 117626000.00
CURI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CURI balance_sheet (annual, 2022-12-31) — Construction In Progress: 5000.00
CURI income_statement (annual, 2022-12-31) — Cost Of Revenue: 51536000.00
CURI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 7752000.00
CURI balance_sheet (annual, 2022-12-31) — Current Assets: 69510000.00
CURI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 14281000.00
CURI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 14281000.00
CURI balance_sheet (annual, 2022-12-31) — Current Liabilities: 30960000.00
CURI cash_flow (annual, 2022-12-31) — Depreciation: 699000.00
CURI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 39990000.00
CURI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 39990000.00
CURI balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 257000.00
CURI income_statement (annual, 2022-12-31) — Diluted Average Shares: 52787000.00
CURI income_statement (annual, 2022-12-31) — Diluted EPS: -0.96
CURI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -50917000.00
CURI income_statement (annual, 2022-12-31) — EBIT: -51681000.00
CURI income_statement (annual, 2022-12-31) — EBITDA: -11691000.00
CURI income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -846000.00
CURI cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 846000.00
CURI cash_flow (annual, 2022-12-31) — End Cash Position: 40507000.00
CURI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -218000.00
CURI cash_flow (annual, 2022-12-31) — Free Cash Flow: -39653000.00
CURI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -5404000.00
CURI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 5404000.00
CURI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -40000.00
CURI income_statement (annual, 2022-12-31) — General And Administrative Expense: 37479000.00
CURI balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
CURI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 68502000.00
CURI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 10999000.00
CURI balance_sheet (annual, 2022-12-31) — Gross PPE: 6664000.00
CURI income_statement (annual, 2022-12-31) — Gross Profit: 26507000.00
CURI balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 0.00
CURI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 3603000.00
CURI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 614000.00
CURI income_statement (annual, 2022-12-31) — Interest Income: 176000.00
CURI income_statement (annual, 2022-12-31) — Interest Income Non Operating: 176000.00
CURI balance_sheet (annual, 2022-12-31) — Invested Capital: 117626000.00
CURI cash_flow (annual, 2022-12-31) — Investing Cash Flow: 62701000.00
CURI balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
CURI balance_sheet (annual, 2022-12-31) — Investments And Advances: 10766000.00
CURI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CURI balance_sheet (annual, 2022-12-31) — Leases: 703000.00
CURI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 4648000.00
CURI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4648000.00
CURI balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 10766000.00
CURI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 965000.00
CURI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -2438000.00
CURI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CURI income_statement (annual, 2022-12-31) — Net Income: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -50917000.00
CURI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -50917000.00
CURI income_statement (annual, 2022-12-31) — Net Interest Income: 176000.00
CURI cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 65269000.00
CURI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 176000.00
CURI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -218000.00
CURI balance_sheet (annual, 2022-12-31) — Net PPE: 4796000.00
CURI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -130000.00
CURI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 49124000.00
CURI income_statement (annual, 2022-12-31) — Normalized EBITDA: -13492000.00
CURI income_statement (annual, 2022-12-31) — Normalized Income: -52339790.00
CURI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -39523000.00
CURI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -4558000.00
CURI income_statement (annual, 2022-12-31) — Operating Income: -51681000.00
CURI income_statement (annual, 2022-12-31) — Operating Revenue: 78043000.00
CURI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 52853000.00
CURI balance_sheet (annual, 2022-12-31) — Other Current Assets: 3118000.00
CURI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2862000.00
CURI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -40000.00
CURI income_statement (annual, 2022-12-31) — Other Gand A: 37479000.00
CURI income_statement (annual, 2022-12-31) — Other Income Expense: 955000.00
CURI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 68502000.00
CURI cash_flow (annual, 2022-12-31) — Other Non Cash Items: -40452000.00
CURI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 539000.00
CURI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 622000.00
CURI balance_sheet (annual, 2022-12-31) — Other Properties: 4991000.00
CURI balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 14986000.00
CURI balance_sheet (annual, 2022-12-31) — Payables: 6065000.00
CURI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 13817000.00
CURI income_statement (annual, 2022-12-31) — Pretax Income: -50550000.00
CURI cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CURI balance_sheet (annual, 2022-12-31) — Properties: 0.00
CURI cash_flow (annual, 2022-12-31) — Purchase Of Business: -2438000.00
CURI cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1497000.00
CURI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -130000.00
CURI balance_sheet (annual, 2022-12-31) — Receivables: 10899000.00
CURI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 51536000.00
CURI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 39990000.00
CURI balance_sheet (annual, 2022-12-31) — Restricted Cash: 500000.00
CURI balance_sheet (annual, 2022-12-31) — Retained Earnings: -241099000.00
CURI cash_flow (annual, 2022-12-31) — Sale Of Investment: 66766000.00
CURI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 40709000.00
CURI income_statement (annual, 2022-12-31) — Selling General And Administration: 78188000.00
CURI balance_sheet (annual, 2022-12-31) — Share Issued: 52853000.00
CURI income_statement (annual, 2022-12-31) — Special Income Charges: -3603000.00
CURI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 6644000.00
CURI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 117626000.00
CURI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 49124000.00
CURI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 378210.00
CURI income_statement (annual, 2022-12-31) — Tax Provision: 367000.00
CURI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CURI balance_sheet (annual, 2022-12-31) — Total Assets: 154113000.00
CURI balance_sheet (annual, 2022-12-31) — Total Capitalization: 117626000.00
CURI balance_sheet (annual, 2022-12-31) — Total Debt: 4648000.00
CURI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 117626000.00
CURI income_statement (annual, 2022-12-31) — Total Expenses: 129724000.00
CURI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 36487000.00
CURI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 84603000.00
CURI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5527000.00
CURI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -55284000.00
CURI income_statement (annual, 2022-12-31) — Total Unusual Items: 1801000.00
CURI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1801000.00
CURI balance_sheet (annual, 2022-12-31) — Working Capital: 38550000.00
CURI income_statement (annual, 2023-12-31) — +Operating Expense: 46837000.00
CURI income_statement (annual, 2023-12-31) — +Total Revenue: 56889000.00
CURI balance_sheet (annual, 2023-12-31) — Accounts Payable: 4765000.00
CURI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 4760000.00
CURI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1729000.00
CURI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 362636000.00
CURI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -500000.00
CURI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 22905000.00
CURI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 22905000.00
CURI cash_flow (annual, 2023-12-31) — Amortization Of Securities: 26000.00
CURI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 18970000.00
CURI income_statement (annual, 2023-12-31) — Basic Average Shares: 53044000.00
CURI income_statement (annual, 2023-12-31) — Basic EPS: -0.92
CURI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 40507000.00
CURI cash_flow (annual, 2023-12-31) — Capital Expenditure: -5000.00
CURI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4648000.00
CURI balance_sheet (annual, 2023-12-31) — Capital Stock: 5000.00
CURI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 37715000.00
CURI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 37715000.00
CURI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
CURI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -123000.00
CURI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 14003000.00
CURI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -16172000.00
CURI cash_flow (annual, 2023-12-31) — Change In Account Payable: -1295000.00
CURI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -4542000.00
CURI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 855000.00
CURI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 270000.00
CURI cash_flow (annual, 2023-12-31) — Change In Payable: -1295000.00
CURI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -5837000.00
CURI cash_flow (annual, 2023-12-31) — Change In Receivables: 6139000.00
CURI cash_flow (annual, 2023-12-31) — Change In Working Capital: 1427000.00
CURI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 6139000.00
CURI cash_flow (annual, 2023-12-31) — Changes In Cash: -2292000.00
CURI balance_sheet (annual, 2023-12-31) — Common Stock: 5000.00
CURI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
CURI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 72646000.00
CURI cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CURI balance_sheet (annual, 2023-12-31) — Construction In Progress: 5000.00
CURI income_statement (annual, 2023-12-31) — Cost Of Revenue: 35553000.00
CURI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1254000.00
CURI balance_sheet (annual, 2023-12-31) — Current Assets: 45290000.00
CURI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 365000.00
CURI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 365000.00
CURI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 14521000.00
CURI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 14521000.00
CURI balance_sheet (annual, 2023-12-31) — Current Liabilities: 23398000.00
CURI cash_flow (annual, 2023-12-31) — Depreciation: 496000.00
CURI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 23401000.00
CURI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 23401000.00
CURI balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 44000.00
CURI income_statement (annual, 2023-12-31) — Diluted Average Shares: 53044000.00
CURI income_statement (annual, 2023-12-31) — Diluted EPS: -0.92
CURI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -48896000.00
CURI balance_sheet (annual, 2023-12-31) — Dividends Payable: 0.00
CURI income_statement (annual, 2023-12-31) — EBIT: -25501000.00
CURI income_statement (annual, 2023-12-31) — EBITDA: -2100000.00
CURI income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -5404000.00
CURI cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 5404000.00
CURI cash_flow (annual, 2023-12-31) — End Cash Position: 38215000.00
CURI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -123000.00
CURI cash_flow (annual, 2023-12-31) — Free Cash Flow: -16177000.00
CURI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -213000.00
CURI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 213000.00
CURI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CURI income_statement (annual, 2023-12-31) — General And Administrative Expense: 29447000.00
CURI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 44943000.00
CURI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 5260000.00
CURI balance_sheet (annual, 2023-12-31) — Gross PPE: 5806000.00
CURI income_statement (annual, 2023-12-31) — Gross Profit: 21336000.00
CURI balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 0.00
CURI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 18970000.00
CURI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 195000.00
CURI income_statement (annual, 2023-12-31) — Interest Income: 1272000.00
CURI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1272000.00
CURI balance_sheet (annual, 2023-12-31) — Invested Capital: 72646000.00
CURI cash_flow (annual, 2023-12-31) — Investing Cash Flow: 14003000.00
CURI balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 0.00
CURI balance_sheet (annual, 2023-12-31) — Investments And Advances: 6354000.00
CURI balance_sheet (annual, 2023-12-31) — Leases: 703000.00
CURI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 4283000.00
CURI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4283000.00
CURI balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 6354000.00
CURI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 671000.00
CURI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -992000.00
CURI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CURI income_statement (annual, 2023-12-31) — Net Income: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -48896000.00
CURI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -48896000.00
CURI income_statement (annual, 2023-12-31) — Net Interest Income: 1272000.00
CURI cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 15000000.00
CURI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1272000.00
CURI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -123000.00
CURI balance_sheet (annual, 2023-12-31) — Net PPE: 4077000.00
CURI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -5000.00
CURI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 27703000.00
CURI income_statement (annual, 2023-12-31) — Normalized EBITDA: 16657000.00
CURI income_statement (annual, 2023-12-31) — Normalized Income: -34077970.00
CURI cash_flow (annual, 2023-12-31) — Operating Cash Flow: -16172000.00
CURI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5191000.00
CURI income_statement (annual, 2023-12-31) — Operating Income: -25501000.00
CURI income_statement (annual, 2023-12-31) — Operating Revenue: 56889000.00
CURI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 53286000.00
CURI balance_sheet (annual, 2023-12-31) — Other Current Assets: 2315000.00
CURI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1398000.00
CURI income_statement (annual, 2023-12-31) — Other Gand A: 29447000.00
CURI income_statement (annual, 2023-12-31) — Other Income Expense: -24161000.00
CURI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 44943000.00
CURI cash_flow (annual, 2023-12-31) — Other Non Cash Items: -20290000.00
CURI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 358000.00
CURI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 651000.00
CURI balance_sheet (annual, 2023-12-31) — Other Properties: 4427000.00
CURI balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
CURI balance_sheet (annual, 2023-12-31) — Payables: 5860000.00
CURI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 7114000.00
CURI income_statement (annual, 2023-12-31) — Pretax Income: -48390000.00
CURI balance_sheet (annual, 2023-12-31) — Properties: 0.00
CURI cash_flow (annual, 2023-12-31) — Purchase Of Business: -992000.00
CURI cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CURI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -5000.00
CURI balance_sheet (annual, 2023-12-31) — Receivables: 4760000.00
CURI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 35553000.00
CURI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 23401000.00
CURI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CURI balance_sheet (annual, 2023-12-31) — Restricted Cash: 500000.00
CURI balance_sheet (annual, 2023-12-31) — Retained Earnings: -289995000.00
CURI cash_flow (annual, 2023-12-31) — Sale Of Investment: 15000000.00
CURI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 17390000.00
CURI income_statement (annual, 2023-12-31) — Selling General And Administration: 46837000.00
CURI balance_sheet (annual, 2023-12-31) — Share Issued: 53286000.00
CURI income_statement (annual, 2023-12-31) — Special Income Charges: -18970000.00
CURI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3999000.00
CURI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 72646000.00
CURI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 27703000.00
CURI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -3938970.00
CURI income_statement (annual, 2023-12-31) — Tax Provision: 506000.00
CURI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CURI balance_sheet (annual, 2023-12-31) — Total Assets: 101022000.00
CURI balance_sheet (annual, 2023-12-31) — Total Capitalization: 72646000.00
CURI balance_sheet (annual, 2023-12-31) — Total Debt: 4648000.00
CURI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 72646000.00
CURI income_statement (annual, 2023-12-31) — Total Expenses: 82390000.00
CURI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 28376000.00
CURI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 55732000.00
CURI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4978000.00
CURI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -44471000.00
CURI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1095000.00
CURI income_statement (annual, 2023-12-31) — Total Unusual Items: -18757000.00
CURI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -18757000.00
CURI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CURI balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
CURI balance_sheet (annual, 2023-12-31) — Working Capital: 21892000.00
CURI income_statement (quarterly, 2024-09-30) — Basic Average Shares: 54850000.00
CURI income_statement (quarterly, 2024-09-30) — Basic EPS: -0.06
CURI balance_sheet (quarterly, 2024-09-30) — Cash Equivalents: 9129000.00
CURI balance_sheet (quarterly, 2024-09-30) — Cash Financial: 459000.00
CURI income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 54850000.00
CURI income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.06
CURI income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
CURI cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 21000.00
CURI income_statement (quarterly, 2024-09-30) — Salaries And Wages: 4797000.00
CURI income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CURI income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -538000.00
CURI income_statement (annual, 2024-12-31) — +Operating Expense: 39104000.00
CURI income_statement (annual, 2024-12-31) — +Total Revenue: 51134000.00
CURI balance_sheet (annual, 2024-12-31) — Accounts Payable: 5608000.00
CURI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6103000.00
CURI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1908000.00
CURI balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1908000.00
CURI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 366508000.00
CURI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
CURI balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
CURI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 19130000.00
CURI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 19130000.00
CURI cash_flow (annual, 2024-12-31) — Amortization Of Securities: -294000.00
CURI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CURI cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
CURI income_statement (annual, 2024-12-31) — Basic Average Shares: 54480000.00
CURI income_statement (annual, 2024-12-31) — Basic EPS: -0.24
CURI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 38215000.00
CURI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4283000.00
CURI balance_sheet (annual, 2024-12-31) — Capital Stock: 5000.00
CURI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 7826000.00
CURI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 32062000.00
CURI cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -4063000.00
CURI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -7010000.00
CURI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -31405000.00
CURI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 8151000.00
CURI cash_flow (annual, 2024-12-31) — Change In Account Payable: 843000.00
CURI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1383000.00
CURI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1131000.00
CURI cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -3822000.00
CURI cash_flow (annual, 2024-12-31) — Change In Payable: 843000.00
CURI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2226000.00
CURI cash_flow (annual, 2024-12-31) — Change In Receivables: -1343000.00
CURI cash_flow (annual, 2024-12-31) — Change In Working Capital: -1808000.00
CURI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1343000.00
CURI cash_flow (annual, 2024-12-31) — Changes In Cash: -30264000.00
CURI balance_sheet (annual, 2024-12-31) — Common Stock: 5000.00
CURI cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -4063000.00
CURI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 57848000.00
CURI cash_flow (annual, 2024-12-31) — Common Stock Payments: -251000.00
CURI balance_sheet (annual, 2024-12-31) — Construction In Progress: 77000.00
CURI balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 77000.00
CURI income_statement (annual, 2024-12-31) — Cost Of Revenue: 25363000.00
CURI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3549000.00
CURI balance_sheet (annual, 2024-12-31) — Current Assets: 39518000.00
CURI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 396000.00
CURI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 396000.00
CURI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 10970000.00
CURI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 10970000.00
CURI balance_sheet (annual, 2024-12-31) — Current Liabilities: 23863000.00
CURI cash_flow (annual, 2024-12-31) — Depreciation: 339000.00
CURI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 19469000.00
CURI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 19469000.00
CURI balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 88000.00
CURI balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 88000.00
CURI income_statement (annual, 2024-12-31) — Diluted Average Shares: 54480000.00
CURI income_statement (annual, 2024-12-31) — Diluted EPS: -0.24
CURI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -12941000.00
CURI balance_sheet (annual, 2024-12-31) — Dividends Payable: 1415000.00
CURI income_statement (annual, 2024-12-31) — EBIT: -13333000.00
CURI income_statement (annual, 2024-12-31) — EBITDA: 6136000.00
CURI income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -2506000.00
CURI cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 2506000.00
CURI cash_flow (annual, 2024-12-31) — End Cash Position: 7951000.00
CURI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -7010000.00
CURI cash_flow (annual, 2024-12-31) — Free Cash Flow: 8151000.00
CURI cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 44000.00
CURI cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -22000.00
CURI income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -44000.00
CURI income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 22000.00
CURI income_statement (annual, 2024-12-31) — General And Administrative Expense: 24670000.00
CURI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 31511000.00
CURI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 6303000.00
CURI balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 6303000.00
CURI balance_sheet (annual, 2024-12-31) — Gross PPE: 5493000.00
CURI income_statement (annual, 2024-12-31) — Gross Profit: 25771000.00
CURI balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 7463000.00
CURI income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CURI income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
CURI cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 80000.00
CURI cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 9000.00
CURI income_statement (annual, 2024-12-31) — Interest Income: 3074000.00
CURI income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3074000.00
CURI balance_sheet (annual, 2024-12-31) — Invested Capital: 57848000.00
CURI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -31405000.00
CURI balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 7463000.00
CURI balance_sheet (annual, 2024-12-31) — Investments And Advances: 11311000.00
CURI balance_sheet (annual, 2024-12-31) — Leases: 703000.00
CURI balance_sheet (quarterly, 2024-12-31) — Leases: 703000.00
CURI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3887000.00
CURI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3887000.00
CURI balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 3848000.00
CURI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 571000.00
CURI balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 571000.00
CURI cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CURI cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CURI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -251000.00
CURI income_statement (annual, 2024-12-31) — Net Income: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -12941000.00
CURI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -12941000.00
CURI income_statement (annual, 2024-12-31) — Net Interest Income: 3074000.00
CURI cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -31405000.00
CURI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3074000.00
CURI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2696000.00
CURI balance_sheet (annual, 2024-12-31) — Net PPE: 3585000.00
CURI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
CURI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 26337000.00
CURI income_statement (annual, 2024-12-31) — Normalized EBITDA: 6180000.00
CURI income_statement (annual, 2024-12-31) — Normalized Income: -12906240.00
CURI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 8151000.00
CURI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2550000.00
CURI income_statement (annual, 2024-12-31) — Operating Income: -13333000.00
CURI income_statement (annual, 2024-12-31) — Operating Revenue: 51134000.00
CURI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 56598110.00
CURI balance_sheet (annual, 2024-12-31) — Other Current Assets: 1228000.00
CURI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 979000.00
CURI income_statement (annual, 2024-12-31) — Other Gand A: 24670000.00
CURI income_statement (annual, 2024-12-31) — Other Income Expense: -2550000.00
CURI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 31511000.00
CURI cash_flow (annual, 2024-12-31) — Other Non Cash Items: -5393000.00
CURI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 257000.00
CURI balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 496000.00
CURI balance_sheet (annual, 2024-12-31) — Other Properties: 4142000.00
CURI balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 24236000.00
CURI balance_sheet (annual, 2024-12-31) — Payables: 7969000.00
CURI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 11518000.00
CURI income_statement (annual, 2024-12-31) — Pretax Income: -12809000.00
CURI balance_sheet (annual, 2024-12-31) — Properties: 0.00
CURI balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CURI cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CURI cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CURI cash_flow (annual, 2024-12-31) — Purchase Of Investment: -38605000.00
CURI cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
CURI balance_sheet (annual, 2024-12-31) — Receivables: 6103000.00
CURI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 25363000.00
CURI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 19469000.00
CURI cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -251000.00
CURI balance_sheet (annual, 2024-12-31) — Restricted Cash: 125000.00
CURI balance_sheet (annual, 2024-12-31) — Retained Earnings: -308414000.00
CURI cash_flow (annual, 2024-12-31) — Sale Of Investment: 7200000.00
CURI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 14434000.00
CURI income_statement (annual, 2024-12-31) — Selling General And Administration: 39104000.00
CURI balance_sheet (annual, 2024-12-31) — Share Issued: 56814000.00
CURI income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CURI income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CURI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6568000.00
CURI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 57848000.00
CURI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 26337000.00
CURI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -9240.00
CURI income_statement (annual, 2024-12-31) — Tax Provision: 132000.00
CURI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CURI balance_sheet (annual, 2024-12-31) — Total Assets: 86182000.00
CURI balance_sheet (annual, 2024-12-31) — Total Capitalization: 57848000.00
CURI balance_sheet (annual, 2024-12-31) — Total Debt: 4283000.00
CURI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 57848000.00
CURI income_statement (annual, 2024-12-31) — Total Expenses: 64467000.00
CURI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 28334000.00
CURI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 46664000.00
CURI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4471000.00
CURI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -13333000.00
CURI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 946000.00
CURI income_statement (annual, 2024-12-31) — Total Unusual Items: -44000.00
CURI income_statement (quarterly, 2024-12-31) — Total Unusual Items: 22000.00
CURI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -44000.00
CURI income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 22000.00
CURI balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 215890.00
CURI balance_sheet (annual, 2024-12-31) — Treasury Stock: 251000.00
CURI balance_sheet (annual, 2024-12-31) — Working Capital: 15655000.00
CURI income_statement (quarterly, 2025-03-31) — +Operating Expense: 7931000.00
CURI income_statement (quarterly, 2025-03-31) — +Total Revenue: 15090000.00
CURI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4775000.00
CURI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7722000.00
CURI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 367319000.00
CURI cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 3513000.00
CURI cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 3513000.00
CURI cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -195000.00
CURI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 57132000.00
CURI income_statement (quarterly, 2025-03-31) — Basic EPS: 0.01
CURI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 7951000.00
CURI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -77000.00
CURI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4187000.00
CURI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5000.00
CURI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 9183000.00
CURI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 33445000.00
CURI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2277000.00
CURI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -2635000.00
CURI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 2070000.00
CURI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1922000.00